未接受抗逆转录病毒治疗个体中低丰度耐药HIV-1变异的系统综述:检测方法、流行率与临床影响
研究设计和方法异质性大,限制可比性,LA-DRVs对一线ART的临床影响仍具挑战。
要点
- 未治疗成人中LA-DRVs流行率跨度0%-100%,检测方法异质性大。
- 仅25项研究聚焦一线NNRTI方案,其中44.0%报告LA-DRVs与病毒学失败显著相关。
- 研究可比性受限,LA-DRVs临床影响尚难定论。
核心结论
- 103项研究因设计和高异质性及检测方法不同而可比性受限,评估LA-DRVs对一线ART的临床影响仍具挑战。
主要发现
- LA-DRVs流行率(携带LA-DRVs个体比例)为0%-100%。
- 技术检测 cutoffs 显示4个对数范围(0.001%-10%)。
- 42/103(40.8%)项研究探讨LA-DRVs对ART的影响;其中25项仅纳入一线非核苷类逆转录酶抑制剂(NNRTI)方案者。
局限性
- 研究设计高度异质性且检测LA-DRVs方法不同,妨碍了103项研究的可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The presence of high-abundance drug-resistant HIV-1 jeopardizes success of antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low-abundance drug-resistant HIV-1 variants (LA-DRVs) at levels <15%-25% of the virus population in antiretroviral (ARV) drug-naive individuals remains controversial. METHODS: We systematically reviewed 103 studies assessing prevalence, detection methods, technical and clinical detection cutoffs, and clinical significance of LA-DRVs in antiretroviral drug-naive adults. RESULTS: In total, 14 919 ARV drug-naive individuals were included. Prevalence of LA-DRVs (ie, proportion of individuals harboring LA-DRVs) was 0%-100%. Technical detection cutoffs showed a 4 log range (0.001%-10%); 42/103 (40.8%) studies investigating the impact of LA-DRVs on ART; 25 studies included only individuals on first-line nonnucleoside reverse transcriptase inhibitor-based ART regimens. Eleven of those 25 studies (44.0%) reported a significantly association between preexisting LA-DRVs and risk of virological failure whereas 14/25 (56.0%) did not. CONCLUSIONS: Comparability of the 103 studies is hampered by high heterogeneity of the studies' designs and use of different methods to detect LA-DRVs. Thus, evaluating clinical impact of LA-DRVs on first-line ART remains challenging. We, the WHO HIVResNet working group, defined central areas of future investigations to guide further efforts to implement ultrasensitive resistance testing in routine settings.
引用
- Mbunkah HA, Bertagnolio S, Hamers RL, et al. Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact. J Infect Dis. 2020. PMID: 31809534. doi:10.1093/infdis/jiz650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。